← Eichor
Condition: Refractory Hyperlipidemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Refractory Hyperlipidemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
Phase 1 · 16 location(s) · Verve Therapeutics, Inc. · NCT06451770A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Phase 1 · 19 location(s) · CRISPR Therapeutics AG · NCT07491172
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.